Skip to content

Mobility, Strength, and Functional Outcomes Before Surgery, at 3 Months, and at 6 Months After Hip Arthroscopy for Femoroacetabular Impingement Syndrome

Mobility, Strength, and Functional Outcomes Before Surgery, at 3 Months, and at 6 Months

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07472400
Enrollment
60
Registered
2026-03-16
Start date
2026-03-01
Completion date
2027-06-30
Last updated
2026-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoroacetabular Impingement Syndrome, Healthy Participants

Keywords

Femoroacetabular impingement syndrome, Physical impairments, Questionnaires, Strength, mobility

Brief summary

The aim of this study is to identify the factors associated with successful rehabilitation following hip arthroscopy for femoroacetabular impingement syndrome and to highlight any persistent functional deficits at different key stages of rehabilitation. This is a controlled multi-observational study. The pathological hip of patients will be compared to their second healthy hip as well as to a healthy control group. Assessments of mobility, strength, functional tests, and questionnaire submissions will take place before the intervention and 3 and 6 months after the intervention.

Interventions

None listed

Sponsors

University of Liege
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Subjects with femoroacetabular impingement syndrome, with corresponding clinical symptoms and signs, as well as validation by imaging * Subjects who have already consulted a surgeon specializing in hip arthroscopic surgery and whose surgery is planned to treat femoroacetabular impingement syndrome * Subjects aged between 18 and 40

Exclusion criteria

* History of rheumatic disease, dysplasia or pediatric disease affecting the hip (Legg-Calvé; superior femoral epiphysiolysis) * Subject who has already undergone surgery on the hip joint * Subjects with a history of injury to the muscles involved in the assessments within the last year

Design outcomes

Primary

MeasureTime frameDescription
Muscle strength in NmPre-intervention, at 3 months and 6 months post-interventionMuscular strength is measured using a fixed dynamometer
Hip mobility in degreePre-intervention, at 3 months and 6 months post-interventionHip mobility is measured using an electronic goniometer
Functional results on the Y Balance TestPre-intervention, at 3 months and 6 months post-interventionThe functional results of the Y balance test will be measured using the composite score.
Functional results in the single-leg squat testPre-intervention, at 3 months and 6 months post-interventionThe functional results of the single-leg squat test will be measured using the SIngle-leg squat Movement Performance scaLe for Individuals with FemoroAcetabular Impingement syndrome (SIMPLAI-FAI). The score on this scale ranges from 0 to 8. A higher score indicates a better functional outcome.
Measurements of patient-reported outcomes using the Hip-Return to Sport After Injury Scale (HIP-RSI)Pre-intervention, at 3 months and 6 months post-interventionAnalysis of scores obtained on the HIP-RSI questionnaire. This questionnaire assesses psychological readiness to resume sports activities following hip surgery. It consists of six items, and the final score ranges from 0 to 100. A higher score indicates greater psychological readiness to return to sports activities.
Measurements of patient-reported outcomes using the International Hip Outcome Tool-12 (iHot-12) questionnairePre-intervention, at 3 months and 6 months post-interventionAnalysis of scores obtained on the iHot-12 questionnaire. This questionnaire assesses the quality of life of young, active patients suffering from hip problems. It consists of 12 items and the final score ranges from 0 to 100. A score of 100 indicates full function and no symptoms, whereas a score of zero signifies maximum limitations and extreme symptoms.

Countries

Belgium

Contacts

CONTACTRaphaël Leroy, PT, PhD candidate
rleroy@uliege.be+32491128430

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 6, 2026